NeuroMetrix shifting to exclusively direct-to-consumer model for Quell 2.0
NeuroMetrix announced updates to its Quell 2.0 commercial strategy. The company is shifting to an exclusively direct-to-consumer model delivered via the QuellRelief.com website, which is said "will allow it to offer the innovative Quell 2.0 system at accessible price points. This streamlined distribution model will allow more people with chronic pain to benefit from the advanced Quell pain relief technology. The new approach will also open the door for more people to take advantage of electrode savings through a subscription service." Shai Gozani, President, and CEO of NeuroMetrix, said, "We believe that everyone living with chronic pain should have the opportunity to experience Quell and determine if it is beneficial to their particular form of chronic pain. Therefore, we have worked over the past several quarters to refine our business model and distribution system to position us to deliver Quell 2.0 at widely attainable price points."